Previous 10 | Next 10 |
Summary Investors continue to compress the National Research Corporation share price in continuation with long-term downtrends. The stock has caught a bid of late as the market continues to reward bottom-line fundamentals over top-line growth. Here I've demonstrated the qualit...
High-yielding dividend stocks are great for long-term investors. What's even better are stocks with high payouts that also increase their dividend payments. And three stocks that made generous rate hikes within the past year are National Research Corporation (NASDAQ: NRC) , Un...
National Research ( NASDAQ: NRC ) declares $0.24/share quarterly dividend , in line with previous. Forward yield 2.69% Payable Oct. 14; for shareholders of record Sept. 30; ex-div Sept. 29. See NRC Dividend Scorecard, Yield Chart, & Dividend Growth. ...
Top 100 Hospitals Excelling Across Seven Aspects of Consumer Loyalty Earn National Honors in Fifth-Annual Consumer Loyalty Awards Eight Hospitals and Health Systems Recognized with Excellence in Patient Experience Award for Outstanding Commitment to Enhancing the Care Journey ...
LINCOLN, Neb., Aug. 12, 2022 (GLOBE NEWSWIRE) -- NRC Health , the leading partner in building Human Understanding through personalized healthcare solutions and data-driven insights, today announced it is now a Supporting Partner of The Beryl Institute , a global network of h...
National Research Corporation (NRC) Q2 2022 Earnings Conference Call August 03, 2022, 11:00 AM ET Company Participants Michael Hays - Founder and Chief Executive Officer Kevin Karas - Chief Financial Officer Conference Call Participants John Lewis - Willi...
National Research press release ( NASDAQ: NRC ): Q2 GAAP EPS of $0.33. Revenue of $37.3M (+2.4% Y/Y). For further details see: National Research GAAP EPS of $0.33, revenue of $37.3M
LINCOLN, Neb., Aug. 02, 2022 (GLOBE NEWSWIRE) -- National Research Corporation, dba NRC Health, (NASDAQ:NRC) today announced results for the second quarter 2022. Q2 2022 financial results compared to Q2 2021: Revenue increased 2% to $37.3 million Operating income decreased 6...
Lincoln, Nebraska, July 19, 2022 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2022 second quarter earnings conference call on Wednesday, August 3, 2022. The Company’s results for the 2022 ...
LINCOLN, Neb., Feb. 09, 2021 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ:NRC) (the “Company,” “we,” or “our”) today announced 2020 fourth quarter and year-end results. Fourth quarter 2020 compared to the fourth quarter 2019: ...
News, Short Squeeze, Breakout and More Instantly...
National Research Corporation Company Name:
NRC Stock Symbol:
NASDAQ Market:
National Research Corporation Website:
MALVERN, Pa., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, is partnering with non-profit This Is My Bra...
MALVERN, Pa., July 31, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that the management team wil...
MALVERN, Pa., July 30, 2024 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders, today announced that it entered into a debt ...